| BMC Cardiovascular Disorders | |
| High platelet reactivity affects the clinical outcomes of patients undergoing percutaneous coronary intervention | |
| Research Article | |
| Zhi-Zhong Liu1  Nai-Liang Tian1  Fei Ye1  Xiao-Fei Gao1  Song Lin1  Jun-Jie Zhang2  Shao-Liang Chen2  Zhen Ge2  | |
| [1] Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, No. 68 Changle road, 210006, Nanjing, China;Department of Cardiology, Nanjing First Hospital, Nanjing Medical University, No. 68 Changle road, 210006, Nanjing, China;Department of Cardiology, Nanjing Heart Center, Nanjing, China; | |
| 关键词: Platelet function test; High platelet reactivity; Drug eluting stent; Stent thrombosis; | |
| DOI : 10.1186/s12872-016-0394-0 | |
| received in 2016-09-13, accepted in 2016-11-07, 发布年份 2016 | |
| 来源: Springer | |
PDF
|
|
【 摘 要 】
BackgroundThe association of platelet reactivity and clinical outcomes, especially stent thrombosis, was not so clear. We sought to investigate whether high platelet reactivity affects clinical outcomes of patients with drug eluting stents (DESs) implantation.MethodsAll enrolled individuals treated with DESs implantation were evaluated by PL-11, using sequentially platelet counting method. The primary end point was the occurrence of definite and probable stent thrombosis at 2 years. The secondary endpoint was major adverse cardiovascular and cerebrovascular events (MACCE), including all cause death, spontaneous myocardial infarction (MI), target vessel revascularization (TVR), and ischemic stroke.ResultsA total of 1331consecutive patients were enrolled at our center. There were 91 patients (6.8 %) identified with high platelet reactivity (HPR) on aspirin, and 437 patients (32.9 %) with HPR on clopidogrel. At 2-year follow-up, the incidence of stent thrombosis was significantly higher in patients with HPR on aspirin (9.9 % vs. 0.4 %, p < 0.001), and HPR on clopidogrel (3.0 % vs. 0.1 %, p < 0.001). There were increased MACCE in the HPR on aspirin group (16.5 % vs. 8.5 %, p = 0.021), mainly driven by the higher all cause death (7.7 % vs. 1.6 %, p = 0.002) and MI (9.9 % vs. 1.9 %, p < 0.001) in the HPR on aspirin group. Similarly, the rate of MACCE was higher in the HPR on clopidogrel group (12.4 % vs. 7.4 %, p = 0.004). No differences in all bleeding and hemorrhagic stroke were observed.ConclusionsThe present study demonstrated that high platelet reactivity on both aspirin and clopidogrel were associated with incremental stent thrombosis following DESs implantation.
【 授权许可】
CC BY
© The Author(s). 2016
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202311108677571ZK.pdf | 817KB |
【 参考文献 】
- [1]
- [2]
- [3]
- [4]
- [5]
- [6]
- [7]
- [8]
- [9]
- [10]
- [11]
- [12]
- [13]
- [14]
- [15]
- [16]
- [17]
- [18]
- [19]
- [20]
- [21]
- [22]
PDF